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Abstract 
Disrupted circadian rhythms and reduced sleep duration are associated with several human 
diseases, particularly obesity and type 2 diabetes, but until recently, little was known about 
the genetic factors influencing these heritable traits. We performed genome-wide association 
studies of self-reported chronotype (morning/evening person) and self-reported sleep 
duration in 128,266 White British individuals from the UK Biobank study. Sixteen variants 
were associated with chronotype (P<5x10-8), including variants near the known circadian 
rhythm genes RGS16 (1.21 odds of morningness, 95% CI [1.15, 1.27], P=3x10-12) and PER2 
(1.09 odds of morningness, 95% CI [1.06, 1.12], P=4x10-10). The PER2 signal has previously 
been associated with iris function. We sought replication using self-reported data from 
89,283 23andMe participants; thirteen of the chronotype signals remained associated at 
P<5x10-8 on meta-analysis and eleven of these reached P<0.05 in the same direction in the 
23andMe study. We also replicated 9 additional variants identified when the 23andMe study 
was used as a discovery GWAS of chronotype (all P<0.05 and meta-analysis P<5x10-8). For 
sleep duration, we replicated one known signal in PAX8 (2.6 minutes per allele, 95% CI [1.9, 
3.2], P=5.7x10-16) and identified and replicated two novel associations at VRK2 (2.0 minutes 
per allele, 95% CI [1.3, 2.7], P=1.2x10-9; and 1.6 minutes per allele, 95% CI [1.1, 2.2], 
P=7.6x10-9). Although we found genetic correlation between chronotype and BMI (rG=0.056, 
P=0.05); undersleeping and BMI (rG=0.147, P=1x10-5) and oversleeping and BMI 
(rG=0.097, P=0.04), Mendelian Randomisation analyses, with limited power, provided no 
consistent evidence of causal associations between BMI or type 2 diabetes and chronotype 
or sleep duration. Our study brings the total number of loci associated with chronotype to 22 
and with sleep duration to three, and provides new insights into the biology of sleep and 
circadian rhythms in humans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Author Summary 
Numerous studies have identified links between too little or too much sleep and circadian 
misalignment with metabolic disorders such as obesity and type 2 diabetes. However, 
cause-and-effect is not easily determined, because of multiple confounding factors affecting 
both sleep patterns and disease risk. Using the first release of the UK Biobank study, which 
combines detailed measurements and questionnaire data with genetic data, we investigate 
the genetics of two self-report sleep measures, chronotype and average sleep duration, in 
128,266 white British individuals. We replicate previous genetic associations and identify 
seven and two novel genetic variants influencing chronotype and sleep duration, 
respectively. Associated variants are located near genes implicated in circadian rhythm 
regulation (RGS16, PER2), near a serotonin receptor gene (HTR6) and another gene 
(INADL) encoding a protein thought to be important in photosensitive retinal cells, cells 
known to communicate with the brain’s primary circadian pacemaker. Using the genetic risk 
factors, we estimate the unconfounded causal associations of BMI and type 2 diabetes on 
sleep patterns (and vice versa) through Mendelian Randomisation. However, we find no 
evidence for causal associations in either direction. The full UK Biobank release of 500,000 
individuals will boost our power to detect causal associations.  
Introduction 
There are strong epidemiological associations between disrupted circadian rhythms, sleep 
duration and disease. A circadian rhythm refers to an underlying 24-hour physiological cycle 
that occurs in most living organisms. In humans, there are clear daily cyclical patterns in 
core body temperature, hormonal and most other biological systems [1]. These cycles are 
important for many molecular and behavioural processes. In particular, circadian rhythms 
are important in regulating sleeping patterns. While each individual has an endogenous 
circadian rhythm, the timing of these rhythms varies across individuals. Those with later 
circadian rhythms tend to sleep best with a late bedtime and late rising time and are often 
referred to as an “owl” or as an “evening” person. Those with earlier rhythms tend to feel 
sleepy earlier in the night and wake up early in the morning and are referred to as a “lark” or 
“morning” person. The remainder of the population falls in between these extremes. This 
dimension of circadian timing, or chronotype, is one behavioural consequence of these 
underlying cycles. Chronotype can be simply assessed by questionnaire and is considered a 
useful tool for studying circadian rhythms [2,3]. 
 
There is substantial evidence for a relationship between short sleep duration, poor quality 
sleep and obesity and type 2 diabetes [4,5]. Eveningness has been associated with poor 
glycaemic control in patients with type 2 diabetes independently of sleep disturbance [6] and 
with metabolic disorders and body composition in middle-aged adults [7]. There is evidence 
from animal models that disruption to circadian rhythms and sleep patterns can cause 
various metabolic disorders [8-10]. For example, mice homozygous for dominant negative 
mutations in the essential circadian gene, Clock, develop obesity and hyperglycaemia [10] 
and conditional ablation of the Bmal1 and Clock genes in pancreatic islets causes diabetes 
mellitus due to defective β-cell function [9]. Despite this evidence, in humans the causal 
nature of the epidemiological associations between sleep patterns, circadian rhythms and 
obesity and type 2 diabetes is unknown. Identifying genetic variants associated with sleep 
duration and chronotype will provide instruments to help test the causality of epidemiological 
associations [11]. 
 
A previous genome-wide association study (GWAS) in 4,251 individuals identified a single 
genetic variant in ABCC9 associated with sleep duration [12]. A subsequent GWAS meta-
analysis including 47,180 individuals identified a single locus for sleep duration near PAX8 
[13]. Fifteen loci associated with chronotype were recently discovered by 23andMe [14] with 
7 of these found to be in close proximity to known circadian rhythm regulation genes.. The 
UK Biobank is a study of 500,000 individuals from the UK aged between 37 and 73 years 
with genome-wide SNP analysis and detailed phenotypic information, including chronotype 
and sleep duration (http://www.ukbiobank.ac.uk/). The UK Biobank study provides an 
excellent opportunity to identify novel genetic variants influencing chronotype and sleep 
duration which will provide insights into the biology of circadian rhythms and sleep and help 
test causal relationships between circadian rhythm and metabolic traits including obesity. 
 
Results 
Sixteen loci associated with chronotype in UK Biobank 
Using self-reported “morningness”, we generated a binary and a continuous chronotype 
score. We performed genome-wide association studies on 16,760,980 imputed autosomal 
variants. Fig 1 presents the overall results for these GWAS. Table 1 presents details of all 
16 loci associated at P<5x10-8. 
 
Fig 1. Manhattan and quantile-quantile (QQ) plots for Chronotype. Summary information 
plots for inverse-normalised (self-report) Chronotype score vs. ~16.8 million imputed genetic 
variants in 127,898 White British individuals in the UK Biobank study. The manhattan plot 
(top) shows association test (-log10 P-value on the y-axis against physical autosomal location 
on the x-axis. The standard genome-wide significance cutoff of P=5x10-8 is shown by the 
horizontal black line. Variants tested had imputation R2>0.4, a Hardy-Weinberg Equilibrium 
(HWE) P-value > 1x10-6 and minor allele frequency (MAF) > 0.1%. The QQ (quantile-
quantile) plot (bottom) identifies some inflation (λGC = 1.097) but this is consistent with 
expected inflation from a highly polygenic trait in such a large sample size [15]. 
 
Table 1. Genetic variants associated with chronotype (as either a continuous or binary 
trait) at P<5x10-8 in the UK Biobank study. Variants highlighted in bold were not identified 
by the 23andMe study, those in italic did not reach genome-wide significance on meta-
analysis and those not highlighted replicate previously reported loci from 23andMe. Genes 
listed are candidate or nearest genes within 250Kb of the lead SNP. Odds ratios correspond 
to risk of morningness over eveningness. Beta, OR and frequency refers to A1. Replication 
data is based on continuous data and as the replication beta is in different units to the 
discovery GWAS beta, a P-value meta-analysis was performed. 
  
Variant Chr:Pos A1/A2 
A1 
Freq 
GWAS 
Continuous 
Beta (SE) 
GWAS 
Continuous 
P 
GWAS 
Binary OR 
(SE) 
GWAS 
Binary P 
Replication 
Beta (SE) 
Replicati
on P 
Combine
d P 
Genes 
rs516134 1:182,553,693 C/T 0.03 0.081 (0.011) 9.00E-13 1.21 (0.032) 3.00E-12 0.295 (0.035) 2.00E-17 7.00E-28 RGS16 
rs11162296 1:77,700,196 G/C 0.84 -0.037 (0.005) 2.00E-12 0.93 (0.011) 1.00E-12 -0.097 (0.015) 2.00E-10 2.00E-21 PIGK, AK5 
rs10157197 1:150,250,636 G/A 0.6 0.025 (0.004) 1.00E-09 1.05 (0.010) 5.00E-07 0.064 (0.011) 1.00E-08 6.00E-17 
PRPF3, 
TARS2 
rs372229746 * 7:102,158,815 G/A 0.55 0.028 (0.005) 4.00E-09 1.06 (0.012) 7.00E-07 0.068 (0.013) 4.00E-07 8.00E-15 
ORAI2, 
RASA4 
rs75804782 2:239,316,043 T/C 0.88 0.030 (0.006) 3.00E-07 1.09 (0.015) 4.00E-10 0.106 (0.018) 4.00E-09 1.00E-14 PER2 
rs76899638 6:55,147,508 
A/AT
G 
0.22 0.026 (0.005) 4.00E-08 1.05 (0.012) 2.00E-07 0.067 (0.014) 4.00E-06 8.00E-13 HCRTR2  
rs77641763 9:140,265,782 C/T 0.88 0.039 (0.006) 5.00E-11 1.07 (0.015) 7.00E-09 0.065 (0.020) 2.00E-03 2.00E-12 EXD3 
rs9961653 18:56,767,671 T/C 0.42 0.023 (0.004) 1.00E-08 1.04 (0.010) 1.00E-06 0.032 (0.012) 6.00E-03 7.00E-10 
RAX, CPLX4, 
LMAN1 
rs2050122 1:19,989,205 T/C 0.2 0.028 (0.005) 2.00E-08 1.06 (0.012) 3.00E-06 0.030 (0.014) 3.00E-02 1.00E-08 HTR6 
rs70944707 * 2:24,257,444 C/CT 0.23 0.030 (0.005) 3.00E-08 1.05 (0.013) 2.00E-05 0.035 (0.016) 3.00E-02 2.00E-08 FKBP1B 
rs72720396 1:91,191,582 A/G 0.77 -0.025 (0.005) 1.00E-07 0.95 (0.010) 3.00E-08 -0.035 (0.014) 2.00E-02 2.00E-08 CALB1 
rs12140153 1:62,579,891 G/T 0.9 0.039 (0.007) 7.00E-09 1.07 (0.017) 4.00E-06 0.043 (0.025) 8.00E-02 3.00E-08 INADL 
rs1075265 2:54,354,927 C/G 0.48 -0.025 (0.004) 2.00E-10 0.95 (0.009) 4.00E-08 -0.010 (0.011) 4.00E-01 4.00E-08 
PSME4, 
ACYP2 
rs4821940 22:40,659,573 T/C 0.45 0.022 (0.004) 3.00E-08 1.05 (0.010) 4.00E-08 0.006 (0.011) 6.00E-01 5.00E-06 SGSM3 
rs12635074 3:55,982,416 T/G 0.68 -0.023 (0.004) 3.00E-08 0.96 (0.009) 2.00E-06 -0.002 (0.012) 8.00E-01 1.00E-05 ERC2 
rs192534763 8:36,202,946 T/C 0.99 0.100 (0.021) 3.00E-07 1.25 (0.057) 2.00E-08 -0.005 (0.055) 9.00E-01 1.00E-04 UNC5D 
 
* Proxies used for replication cohort: rs4729854 for rs372229746 (r
2
=0.33), and rs12621152 for rs70944707 (r
2
=0.33).
Replication and validation of UK Biobank chronotype associations 
Analysing UK Biobank data with that from 23andMe provides evidence that at least 13 of the 
16 are associated with chronotype. Thirteen of the chronotype signals remained at P<5x10-8 
in a meta-analysis including UK Biobank and 89,283 individuals from 23andMe [14], of which 
11 reached P<0.05 in the same direction in 23andMe alone, and 15 of the 16 UK Biobank 
signals were in the same direction (binomial P=0.0002) (Table 1). We also attempted to 
validate the associations in 6,191 European-Ancestry from the Chronogen consortium and 
2,532 Korean Ancestry individuals from the Insomnia, Chronotype and sleep EEG (ICE) 
consortium that used “Gold standard” chronotype questionnaire (Munich Chronotype 
Questionnaire – MCTQ and Morningness-Eveningness Questionnaire - MEQ). Given the 
sample size of 5% of the discovery UK Biobank study we assessed directional consistency 
rather than testing for replication P-values <0.05 or 0.05/16. In the European-Ancestry 
individuals 11 of the 16 signals were represented. Nine of these 11 variants had the same 
direction of effect as the discovery UK Biobank cohort (binomial test P=0.03) and one 
replicated at Bonferroni significance (rs12140153, P=0.003). In the Korean study, 9 signals 
were represented, four of which had the same direction of effect as the discovery UK 
Biobank cohort (binomial test P=1.00). The level of directional consistency in these two 
smaller studies is consistent with what would be expected in cohorts <5% the size of our 
discovery cohort. 
 
Replication of previously reported chronotype associations 
A 23andMe study recently identified 15 loci associated with chronotype [14]. All of the 15 
signals were replicated in our study with P<0.05 in the same direction and had meta-analysis 
P<5x10-8 (S1 Table). We performed a conditional analysis of our lead chronotype variants 
by adjusting for the 15 known signals (S2 Table), in order to identify which of our loci 
coincided with those of Hu et al. [14]. Seven of our 13 replicated signals remained 
associated at P<5x10-8 (see Table 1). The addition of these 7 loci brings the number   
associated with chronotype to 22 (full list in S3 Table). 
 
The chronotype-associated variants occur near genes known to be important in 
photoreception and circadian rhythms 
The variant most strongly associated with chronotype, rs516134 (OR for morningness=1.21, 
95% CI [1.16, 1.26], binary P=3.7x10-12, continuous P=8.9x10-13) occurs near RGS16, which 
is a regulator of G-protein signalling and has a known role in circadian rhythms [16] (Table 1 
and Fig 2). Another signal occurs near PER2 (lead variant rs75804782, OR=1.09, 95% CI 
[1.06, 1.12], binary P=7.2x10-10, continuous P=3.2x10-7; Fig 3). PER2 is a well-known 
regulator of circadian rhythms [17-22] and contains a variant, rs75804782, recently shown to 
be associated with iris formation [23] that is in LD (r2 = 0.65, D’ = 0.97) with our reported lead 
SNP. As there is a reported link between season and reported chronotype [24], we carried 
out a sensitivity analysis in which we adjusted for month of attendance (to assessment 
centre); all associations remained genome-wide significant for the reported variants. We 
tested for enrichment of specific biological and molecular pathways using MAGENTA (Meta-
Analysis Gene-set Enrichment of variaNT Associations) [25] but none had a clear link to 
circadian rhythms (S4 Table). 
 
Fig 2. LocusZoom plot of Chronotype associations in the RGS16 locus. The plot 
displays -log10 P-value on the y-axis and physical position on the x-axis. Points identify 
individual variants whose colour indicates their LD r2 with lead variant rs516134. The blue 
line indicates pre-calculated recombination rates (in cM/Mb) at each position. Variants with 
association P-values > 0.01 were omitted for clarity. 
 
Fig 3. LocusZoom plot of Chronotype associations in the PER2 locus. Variants are 
coloured by their LD r2 with lead variant rs75804782 and those with association P-values > 
0.01 were omitted for clarity. 
 
Three loci associated with sleep duration 
We performed genome-wide association studies on a binary sleep phenotype and a 
continuous sleep duration score for 16,761,225 imputed variants. Fig 4 presents the overall 
results for these GWAS. Three loci reached genome-wide significance. The most strongly 
associated variant was rs62158211 with an average 2.6 minute (95% CI [1.9, 3.2], 
P=5.7x10-16) per-allele change in sleep duration and occurs at the previously reported 
association signal near PAX8 [13]. We identified two, novel, conditionally independent, 
signals that were located ~900kb apart, one upstream and the other downstream of VRK2. 
The downstream variant, rs17190618, has an average per allele effect of 2.0 minutes (95% 
CI [1.3, 2.7], P=1.2x10-9) on sleep duration. The upstream variant, rs1380703 (which is not 
correlated with rs17190618, r2=0.002), has an average per allele effect of 1.6 minutes (95% 
CI [1.1, 2.2], P=7.6x10-9) on sleep duration. On adjusting for month of assessment, we saw 
similar associations for both rs62158211 (P=3x10-16) and rs1380703 (P=6x10-9), with no 
change for rs17190618. Table 2 shows the three sleep duration loci and their lead variants. 
Fig 5 shows locus zoom plots of the VRK2 association signals. We did not replicate the 
association of a previously reported variant in ABCC9 [12] with sleep duration (rs11046205, 
0.1mins, 95% CI [-0.6, 0.7], P=0.83). 
Fig 4. Manhattan and quantile-quantile (QQ) plots for Chronotype. Summary information plots for inverse-normalised (self-report) Sleep 
Duration vs. ~16.8 million imputed genetic variants in 127,573 White British individuals in the UK Biobank study. The manhattan plot (top) 
shows association test (-log10 P-value on the y-axis against physical autosomal location on the x-axis with the standard genome-wide 
significance cutoff of P=5x10-8 shown by the horizontal black line. Variants tested had imputation R2>0.4, a Hardy-Weinberg Equilibrium (HWE) 
P-value > 1x10-6 and minor allele frequency (MAF) > 0.1%. The Sleep Duration QQ plot (bottom) identifies some inflation (λGC = 1.097) but, as 
with Chronotype, this is consistent with expected inflation from a highly polygenic trait in such a large sample size [15]. 
 
Table 2. Three loci associated with sleep duration and their lead variants. Genes listed are candidate genes at each locus. Beta, OR and 
frequency refers to A1. Because the replication beta is in different units to the discovery GWAS beta, a P-value meta-analysis was performed. 
Beta units are in hours. 
Variant Chr:Pos A1/A2 A1 Freq 
GWAS 
Continous 
Beta (SE) 
GWAS 
Continous 
P 
GWAS 
Binary 
OR (SE) 
GWAS 
Binary P 
Replication 
Beta (SE) 
Replication 
P 
Combined 
P 
Gene 
rs62158211 2:114,106,139 G/T 0.79 
-0.039 
6E-16 
0.94 
1E-07 
-0.053 
(0.009) 
4E-9 2E-23 PAX8 
(0.005) (0.011) 
rs17190618 2:58,882,765 A/T 0.84 
-0.033 
1E-09 
0.96 
3E-04 
-0.035 
(0.011) 
1E-3 5E-12 VRK2 
(0.005) (0.013) 
rs1380703 2:57,941,287 A/G 0.62 
0.025 
8E-09 
1.06 
8E-08 
0.021 
(0.008) 
1E-2 3E-10 VRK2 
(0.004) (0.011) 
 
Fig 5. LocusZoom plots of Sleep Duration associations in the VRK2 locus. Both plots show the same locus but each highlights a different 
lead variant: rs1380703 (left) and rs17190618 (right). Variants with association P-values > 0.01 were omitted for clarity. The two leads variants 
represent separate signals. 
 
 
Replication of novel sleep duration hits 
To replicate the two novel sleep duration hits we used data from 47,180 individuals from a 
published study [13]. The variant rs17190618 replicated with effect size = 2.1 minutes (95% 
CI [0.8, 3.3], P=0.001, meta-analysis P=5x10-12). The variant rs1380703 replicated with 
effect size = 1.3 minutes (95% CI [0.3, 2.2], P=0.01, meta-analysis P=3x10-10). 
 
Sleep duration and chronotype are heritable and genetically correlated with BMI and 
psychiatric disease  
Using LD-score regression we estimated the heritability of chronotype and sleep duration 
within UK Biobank to be 0.12 (0.007), and 0.07 (0.007), respectively. There was no evidence 
of a genetic correlation between sleep duration and chronotype (rG=0.0177, P=0.70). 
Chronotype was nominally genetically correlated with BMI (rG=0.056, P=0.048), but not 
Type 2 diabetes (rG=0.004, P=0.99). As the relationship between sleep duration with BMI 
and risk of T2D is U-shaped (see S1 Fig), we defined two further binary phenotypes; 
undersleepers (<7  vs. 7-8 hours) and oversleepers (>8 vs. 7-8 hours). There was a strong 
genetic correlation between undersleeping and BMI (rG=0.147, P=1x10-5), but not T2D 
(rG=0.022,P=0.79). There was also a genetic correlation between oversleeping and both 
BMI (rG=0.097, P=0.039) and T2D (rG=0.336, P=0.001). We also performed LD-score 
regression analyses against a range of other diseases and traits where GWAS summary 
statistics are publically available (S5 Table). Schizophrenia was genetically correlated (after 
adjusting for the number of tests) with hours slept (rG=0.26, P=5x10-10), oversleeping 
(rG=0.35, P=6x10-8), undersleeping (rG=-0.14, P=2x10-3) and chronotype (rG=-0.12, 
P=2x10-4).  
 
Mendelian randomisation analyses provide no consistent evidence that higher BMI 
affects self-reported morningness or vice-versa 
The genetic correlations we observed provide general estimates that capture pleiotropic 
variants (those that affect both traits through different pathways) and associations that are 
secondary to a variant affecting a trait that causally influences the second trait. Using a 
genetic risk score of 69 known BMI variants [26] (listed in S6 Table) as an instrumental 
variable, we next performed Mendelian randomisation analyses in the UK Biobank study to 
test the potential causal role of BMI in chronotype and sleep. Instrumental variables 
analyses using variants and their effect sizes identified by previous studies [26] provided no 
consistent evidence that BMI causally affects  self-reported “morningness” (S7 Table). 
Association statistics of the BMI variants with chronotype are given in S6 Table. We 
repeated these analyses using a genetic risk score consisting of 55 type 2 diabetes SNPs 
[27] and did not find any evidence of causality. Performing the reciprocal Mendelian 
randomization analysis using a genetic risk score of the 13 replicated chronotype variants, 
with effect sizes obtained from 23andMe, we found no consistent evidence in the UK 
Biobank data that morningness or eveningness leads to higher BMI (S7 Table). Association 
of the chronotype-associated variants with BMI are given in S8 Table. 
 
No evidence that BMI and Type 2 diabetes are causally associated with sleep duration 
Using the same genetic risk score of 69 known BMI variants as an instrument, we saw no 
consistent evidence that higher BMI increased an individual’s likelihood of being an 
undersleeper (IVreg2 P=0.95, IVW P=0.04) or an oversleeper (IVreg2 P=0.29, IVW P=0.62) 
in the UK Biobank data (S7 Table). Because there were only three genetic variants of small 
effect associated with sleep duration, we did not perform any Mendelian Randomisation 
analyses of sleep on BMI or type 2 diabetes risk. 
 
 
Discussion 
We performed a genome-wide association study of sleep duration and morningness in 
128,266 individuals from the UK Biobank study. We discovered and replicated two novel loci 
associated with sleep duration. Through replication in a study of 89,823 individuals from 
23andMe we found 13 loci associated with chronotype at P<5x10-8. Together with a recent 
study from 23andMe [14] this takes the number of replicated loci for being a morning person 
to 22 (7 not reported in the 23andMe study). These loci occur in or near circadian rhythm 
and photoreception genes and provide new insights into circadian rhythm and sleep biology 
and their links to disease. 
 
The two novel sleep duration association signals occur upstream and downstream of VRK2 
(vaccinia related kinase 2). VRK2 is a serine/threonine kinase important in several signal 
transduction cascades, and variants near VRK2 are associated with schizophrenia [28] and 
epilepsy [29]. The two sleep duration variants we identified do not represent the same 
signals as those associated with schizophrenia at genome wide significance but one is 
associated with schizophrenia (based on publically available data from the schizophrenia 
genetics consortium (rs1380703) at P=2x10-5, with the allele associated with more sleep 
being associated with higher risk of schizophrenia). Furthermore, the variants associated 
with epilepsy and schizophrenia at genome wide significance in previous studies are 
associated with sleep duration in UK Biobank (epilepsy lead variant rs2947349 [29], P=2x10-
5 and schizophrenia lead variant [28] rs11682175 P=3x10-5) but did not reach genome wide 
significance. We also observed genetic correlation between sleep duration and 
schizophrenia using LD-score regression (rG=0.26, P=5x10-10). Further work is required to 
determine whether variation in VRK2 either has independent associations with both sleep 
and schizophrenia or whether there is some causal link between sleep duration and pattern 
and schizophrenia and epilepsy. 
 
Several of the loci that we identified as associated with chronotype contain genes that have 
a known role in circadian rhythms. The most strongly associated variant, rs516134, occurs 
20kb downstream of RGS16 (regulator of G protein signalling 16). RGS16 has recently been 
shown to have a key role in defining 24 hour rhythms in behaviour [16]. In mice, gene 
ablation of Rgs16 lengthens the circadian period of behavioural rhythm [16]. By temporally 
regulating cAMP signalling, Rgs16 has been shown to be a key factor in synchronising 
intercellular communication between pacemaker neurons in the suprachiasmatic nucleus 
(SCN), the centre for circadian rhythm control in humans. 
 
The association signal with lead SNP rs75804782 occurs ~100kb upstream of PER2 (Period 
2). Per2 is a key regulator of circadian rhythms and is considered one of the most important 
clock genes, and, under constant darkness, Per2 knockout mice show arrhythmic locomotor 
activity [17-22]. This locus also contains a variant that has recently been shown to be 
associated with iris furrow contractions [23]. Our signal is very likely to represent the same 
association and suggests a link between iris function and chronotype (rs75804782 has an 
LD r2 = 0.65 and D’ = 0.97 with the reported lead SNP, rs3739070). Larsson et al. [23] 
suggest TRAF3IP1 as the most likely candidate gene at the locus because of its critical role 
in the cytoskeleton and neurogenesis. Further work is needed to elucidate whether the 
chronotype association at this locus acts through PER2 or TRAF3IP1. 
 
Four of the 22 chronotype loci had missense variants in LD (r2>0.8) with the lead variant 
(RGS16, EXD3, INADL and HCRTR2; see S9 Table). The INADL variant association is 
particularly interesting as INADL (InaD-like) encodes a protein that has been thought to be 
important in organising and maintaining the “intrinsically photosensitive retinal ganglion 
cells”, cells that are known to communicate directly with the suprachiasmatic nucleus, the 
primary circadian pacemaker in mammals [30]. This is compelling evidence that INADL is 
involved in the human circadian rhythm pathway. 
Several of the variants associated with chronotype are also associated with BMI and we 
found genetic correlation between chronotype and sleep duration and BMI. There is 
substantial evidence for a role of sleep disruption and circadian rhythms in metabolic 
disease [1]. Data from animal models and epidemiology provide strong evidence that sleep 
quality or disrupted circadian rhythms can cause metabolic diseases including obesity and 
type 2 diabetes [4-6,8-10]. Our Mendelian Randomisation analyses provided no consistent 
evidence for a role of higher BMI leading to increased self-reported morningness. These 
Mendelian Randomisation results are consistent with those from the recent study from 
23andMe [14]. 
There are some important limitations to our study. First, chronotype and sleep duration were 
self-reported and are subject to reporting bias (e.g. obese individuals may be more likely to 
falsely claim to be morning people). Second, whilst we did not find any evidence that overall 
chronotype or sleep duration causally lead to obesity or type 2 diabetes, it is possible that 
sub-pathways of genes involved in, for example, feeding behaviour may be important in both 
obesity and chronotype regulation. Third, the identified variants only account for a small 
amount of the variation in chronotype and sleep duration and we therefore had limited power 
to detect an effect of these variants on BMI or type 2 diabetes risk. The availability of the full 
UK Biobank study of 500,000 will provide further insight into this relationship. 
 
In conclusion, we have identified novel genetic associations for chronotype and sleep 
duration. The chronotype loci cluster near genes known to be important in determining 
circadian rhythms and will provide new insights into circadian regulation. Our results provide 
new insights into circadian rhythm and sleep biology and their links to disease. 
 
 
Materials and Methods 
Ethics Statement 
This study was conducted using the UK Biobank resource. Details of patient and public 
involvement in the UK Biobank are available online (www.ukbiobank.ac.uk/about-biobank-
uk/ and https://www.ukbiobank.ac.uk/wp-content/uploads/2011/07/Summary-EGF-
consultation.pdf). No patients were specifically involved in setting the research question or 
the outcome measures, nor were they involved in developing plans for recruitment, design, 
or implementation of this study. No patients were asked to advise on interpretation or writing 
up of results. There are no specific plans to disseminate the results of the research to study 
participants, but the UK Biobank disseminates key findings from projects on its website. 
 
Discovery Samples 
We used 128,266 individuals of British descent from the first UK Biobank genetic data 
release (see http://biobank.ctsu.ox.ac.uk). British-descent was defined as individuals who 
both self-identified as white British and were confirmed as ancestrally Caucasian using 
principal components analyses (http://biobank.ctsu.ox.ac.uk). Of these individuals, 120,286 
were classified as unrelated, with a further 7,980 first- to third-degree relatives of these. As 
the association tests were carried out in BOLT-LMM [31], which adjusts for relationships 
between individuals and corrects for population structure, we included all 128,266 related 
white British individuals in the association analyses.  
 
Genotyping and quality control 
We used imputed variants provided by the UK Biobank. Details of the imputation process are 
provided at the UK Biobank website (see http://biobank.ctsu.ox.ac.uk). For this study we only 
included the ~16.8M imputed variants with an imputation R2 ≥ 0.4, MAF ≥ 0.001 and with a 
Hardy–Weinberg equilibrium P>1x10-5. 
 
Phenotypes 
Chronotype 
UK Biobank provides a single measure of Chronotype, from which we produced a 
continuous and a dichotomous phenotype. Chronotype (or morningness) is a self-reported 
measure and asks individuals to categorise themselves as “Definitely a ‘morning’ person”, 
“More a ‘morning’ than ‘evening’ person”, “More an ‘evening’ than a ‘morning’ person”, 
“Definitely an ‘evening’ person” or “Do not know”, which we coded as 2, 1, -1, -2 and 0 
respectively, in our raw continuous “score”. Individuals had the option not to answer; these 
individuals were set to missing. We then produced a normally distributed phenotype by 
adjusting the raw phenotype for age, gender and study centre (categorical) and inverse 
normalising the resulting residuals. The dichotomous chronotype trait defines morning 
people (“Definitely a ‘morning’ person” and “More a ‘morning’ than ‘evening’ person”) as 
cases and evening people (“Definitely an ‘evening’ person” and “More an ‘evening’ than a 
‘morning’ person”) as controls. All other individuals are coded as missing. All results reported 
for continuous chronotype refer to the inverse-normalised residualised chronotype “score”. 
For interpretable results, however, we report effect sizes using the odds ratios of the 
dichotomous chronotype phenotype. A total number of 127,898 and 114,765 individuals 
were available with non-missing continuous and binary chronotype phenotypes, respectively, 
for the association tests; for the Mendelian Randomisation this became 119,935 and 
107,634 respectively. 
 
Sleep duration 
The UK Biobank also provides self-reported “sleep duration”, in which individuals were 
asked to provide the average number of hours slept in a 24-hour period. The phenotype was 
derived by first excluding individuals reporting greater than 18 hours sleep, then adjusting for 
age, gender and study centre (categorical) and obtaining the model residuals and finally 
inverse-normalising to assure a normally distributed phenotype. When reporting results for 
the continuous sleep duration phenotype, we are referring to the inverse-normalised 
phenotype, though we report effect sizes of the residualised phenotype to allow easier 
interpretation of results. There were 127,573 individuals with reported sleep duration 
available for the association tests, with 119,647 available for the MR analyses. 
 
“Oversleepers” and “Undersleepers” 
These two dichotomous phenotypes share the same set of controls; those individuals that 
reported sleeping either 7 or 8 hours (81,204 individuals). In oversleepers, cases (10,102 
individuals) are those reporting 9 or more hours sleep on average, whereas undersleeper 
cases (28,980 individuals) are those reporting 6 or fewer hours. 
 
BMI 
The UK Biobank provided a BMI (weight (kg)/height2) measurement and an estimate based 
on electrical impedance analyses. To help avoid reporting error we excluded individuals with 
significant differences (>4.56 SDs) between these two variables where both were available. 
If only one of these measurements was available this was used. We corrected BMI by 
regressing age, sex, study centre, and the first 5 within-British principal components and 
taking residual values. We then inverse normalised the residuals. A total of 119,684 white-
British individuals with BMI and genetic data were available for the Mendelian 
Randomisation analyses. 
 
Type 2 diabetes 
Individuals were defined as having T2D if they reported either T2D or generic diabetes at the 
interview stage of the UK Biobank study. Individuals were excluded if they reported insulin 
use within the first year of diagnosis. Individuals reportedly diagnosed under the age of 35 
years or with no known age of diagnosis were excluded, to limit the numbers of individuals 
with slow-progressing autoimmune diabetes or monogenic forms. Individuals diagnosed with 
diabetes within the last year of this study were also excluded as we were unable to 
determine whether they were using insulin within this time frame.  A total of 4,040 cases and 
113,735 controls within the white British subset of UK Biobank were identified with genetic 
data available.  
 
Genome-wide association analysis 
To perform the association tests, we used BOLT-LMM [31] to perform linear mixed models 
(LMMs) in the 128,266 individuals. We used BOLT-LMM as it adjusts for population structure 
and relatedness between individuals whilst performing the association tests with feasible 
computing resources. As it adjusts for population structure and relatedness, it allowed us to 
include the additional 7,980 related individuals and therefore improved our power to detect 
associations. To calculate the relationships between individuals, we provided BOLT-LMM a 
list of 328,928 genotyped SNPs (MAF>5%; HWE P>1x10-6; missingness<0.015) for the 
individuals included in the association analysis and used the 1000 Genomes LD-Score table 
provided with the software. 
 
As the continuous phenotypes were derived by adjusting for age, gender and study centre, 
the LMM only included chip (BiLEVE vs. UKBiobank arrays) as a covariate at run-time (see 
http://www.ukbiobank.ac.uk/wp-
content/uploads/2014/04/UKBiobank_genotyping_QC_documentation-web.pdf). The binary 
phenotypes were unadjusted and so included age, gender and chip at run-time. BOLT-LMM 
reported no improvement of the non-infinitesimal mixed model test over the standard 
infinitesimal test and so all association results reported in this paper are for the infinitesimal 
model [31]. 
  
Chronotype replication analyses 
Participants (N=89,283) were from the customer base of 23andMe, Inc. The descriptions of 
the samples, genotyping and imputation are in [14]. Of the 16 chronotype-associated 
variants for which we attempted replication, 10 were available from imputation from the 1000 
Genomes imputation panel phase 1 pilot. An additional 4 were imputed from the phase 1 
version 3 1000 Genomes imputation panel. The final two could not be imputed. We used 
http://analysistools.nci.nih.gov/LDlink/ to find proxies --the best available were rs4729854 for 
rs372229746 (r2=0.33), and rs12621152 for rs70944707 (r2=0.33). We meta-analysed P-
values from the discovery and replication samples using sample size weighting implemented 
in METAL [32]. 
 
Chronotype validation analyses 
Genotypes consisting of both directly typed and imputed SNPs were used for the individual 
GWAS [12]. To avoid over-inflation of test statistics due to population structure or 
relatedness, we applied genomic control for the independent studies and meta-analysis. 
Linear regression for associations with normalised chronotype was performed (see [12] for 
packages used) under an additive model, with SNP allele dosage as predictor and with age, 
age2, gender, normalised sleep duration, season of assessment (dichotomized based on 
time of the year, and day-light savings time – DST or standard zone time assessments) as 
covariates. A fixed-effects meta-analysis was conducted with GWAMA (Genome-Wide 
Association Meta-Analysis) [33] using the inverse-variance-weighted method and low 
imputation quality (Rsq/proper_info < 0.3) were dropped from the meta-analysis.  
Pathway and functional annotation analyses 
Pathway analyses were carried out in MAGENTA[25] using all available libraries provided 
with the software. We included all imputed variants with association P<1x10-5 from the 
continuous chronotype trait. For the results presented in S4 Table, we used gene upstream 
and downstream limits of 250Kb, excluded the HLA region (default setting) and set the 
number of GSEA (Gene Set Enrichment Analysis) [34,35] permutations at 10,000 (default). 
We used HaploReg v4.1[36] to annotate any coding variants within LD r2 > 0.8 of the lead 
variant at each locus. 
 
LocusZoom Plots 
LocusZoom plots (Figs 2, 3 and 5) were created using the LocusZoom tool [37] (found at 
http://locuszoom.sph.umich.edu/locuszoom/) by uploading summary statistics from the 
Chronotype and sleep duration GWAS. For the background LD structure, we selected the 
“1000 Genomes Nov 2014 EUR” panel.  
Genetic correlation analyses 
Genetic correlations (see [38] for methodology) between traits were calculated using the LD 
Score Regression software LDSC (available at https://github.com/bulik/ldsc/) [39]. Summary 
statistics of our traits outputted by BOLT-LMM were first “munged”, a process that converts 
the summary statistics to a format that LDSC understands and aligns the alleles to the 
Hapmap 3 reference panel, removing structural variants and multi-allelic and strand-
ambiguous SNPs. Genetic correlations were then calculated between our phenotypes and a 
set of 101 phenotypes for which summary statistics are publicly available (full list in S5 
Table). We used precomputed LD structure data files specific to Europeans of HAPMAP 3 
reference panel, obtained from (http://www.broadinstitute.org/~bulik/eur_ldscores/) as 
suggested on the LDSC software website. 
 
Mendelian Randomisation IV analysis 
The 13 variants in Table 1 which reached P<5x10-8 in combined analyses were used as 
chronotype instruments in the Mendelian Randomisation analyses. Where binary and 
continuous traits shared a locus, we selected the top variant of the continuous trait over that 
of the binary. For loci that reach GW-significance in the binary trait only, we selected the top 
variant but used the effect size from the continuous trait. 
 
To test for a causal effect of BMI on chronotype and sleep-duration, we selected 69 of 76 
common genetic variants that were associated with BMI at genome wide significance in the 
GIANT consortium in studies of up to 339,224 individuals (S6 Table) [26]. We limited the 
BMI SNPs to those that were associated with BMI in the analysis of all European ancestry 
individuals and did not include those that only reached genome-wide levels of statistical 
confidence in one sex or one stratum only. Variants were also excluded if known to be 
classified as a secondary signal within a locus. Three variants were excluded from the score 
due to potential pleiotropy (rs11030104 [BDNF reward phenotypes], rs13107325 [SLC39A8 
lipids, blood pressure], rs3888190 [SH2B1 multiple traits]), three due to being out of HWE 
(rs17001654, rs2075650 and rs9925964) and the last variant due to not being present in the 
imputed data (rs2033529). 
 
For testing reverse causality of type 2 diabetes on our sleep phenotypes, we used 55 of 65 
common variants (listed in S6 Table) known to be associated with type 2 diabetes at 
genome wide significance in a meta-analysis of 34,840 cases and 114,981 [27], excluding 
those known or suspected to be pleiotropic. 
 
We performed the Mendelian Randomisation analysis two ways; firstly using instrumental 
variables (IV) using STATA’s “IVreg2” function [40] and secondly through the inverse-
variance weighted (IVW) and MR-Egger methods described in [41]. Analyses were 
performed in STATA 13.1 (StataCorp. 2013. Stata Statistical Software: Release 13. College 
Station, TX: StataCorp LP.). 
 
In the instrumental variables method, we generated genetic risk scores (GRS) for BMI and 
type 2 diabetes using the published list of associated variants and their respective betas. For 
Chronotype, we generated a GRS using the thirteen replicated variants and their respective 
betas from 23andMe summary statistics. Using the IVreg2 command, we performed two-
stage least squares estimation to calculate the effect of predicted exposure (through the 
GRS) on the continuous outcome traits. For binary outcomes (type 2 diabetes, undersleeper 
and oversleeper), we manually carried out the two-stage process by regressing the exposure 
trait on its GRS and storing both predicted values and residuals. We then used these 
predicted values and residuals as independent variables in a logistic regression where the 
dependent variable was the binary outcome. 
 
The inverse-variance weighted (IVW) method is equivalent to a meta-analysis of the 
associations of the individual instruments and uses associations between the instruments 
and both the exposure and the outcome to estimate the additive effect of the instruments 
combined [41]. The MR-Egger method is a modification to the IVW method that allows the 
inclusion of “invalid” instruments (i.e. those that don't satisfy all three conditions), by 
performing Egger regression using the summary data of the variants. The IVW and Egger 
methods operate under the assumption that all instruments are valid, in that they satisfy the 
three IV conditions: the genetic variants are 1) independent of confounders, 2) associated 
with the exposure and 3) independent of the outcome.  The MR-Egger method, however, 
accounts for the fact that genetic variants could be pleiotropic and may influence the 
outcome via pathways other than through the exposure and therefore the resulting 
association between genetic instruments and the outcome should not be biased by invalid 
instruments and pleiotropy. The MR-Egger method was used purely as a sensitivity test for 
the IVW method and so MR-Egger results were not considered if the IVW result did not 
reach nominal significance. 
 
For the IVW and MR-Egger methods, associations of genetic instruments (variants) with 
both exposure and outcome phenotypes were generated in STATA by regressing the 
phenotype against the instrument while adjusting for covariates. As a further sensitivity test, 
we also repeated these analyses by replacing exposure phenotype-variant associations with 
their respective published betas and found only slight differences in betas and P-values, 
though all exposure-outcome associations remained non-significant. 
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Supporting Information 
S1 Table. Replication of 23andMe lead GW-significant variants (see Hu et al., 2015). 
The combined P-value was generated by meta-analysing the 23andMe and UKB continuous 
chronotype P-values in the meta-analysis software METAL. 
S2 Table. Conditional analysis to identify loci independent to those reported in Hu et 
al., 2015. We retested our lead chronotype variants while adjusting for all 15 previously 
described variants. LD r2 was calculated between our lead variant and those of 23andMe if 
they were within 500kb of one another by using the 120,286 unrelated white British 
individuals in UK Biobank. Significance is lost for variants rs516134, rs11162296, 
rs75804782, rs10157197, rs12140153 and rs76899638 and so we consider these to belong 
to the same loci as previously reported variants. Our remaining variants are still genome-
wide significant. 
S3 Table. List of 22 loci, including 15 previously described by 23andMe and 7 in this 
study. Where a locus is shared between studies, meta-analysis P-values were compared 
between the lead variants and the one with lowest P-value selected. 
S4 Table. MAGENTA pathways reaching nominal GSEA P-value (95% cutoff) of 0.05 or 
smaller, ordered by GSEA P-value (95% cutoff). 
S5 Table. LD Score genetic trait correlations (rG) and P-values. Correlations with P-
values < 4.95E-4 (0.05/101) are highlighted green. Those with P-values < 4.95E-3 are 
highlighted yellow. 
S6 Table. Summary of the 76 body mass index (BMI) and 65 type 2 diabetes (T2D) 
SNPs used in the Mendelian Randomisation analyses. GIANT (BMI) and DIAGRAM 
(T2D) betas were used as weights in the genetic risk scores. UK Biobank betas (SEs) and P-
values are reported for inverse-normalised BMI and Chronotype; log-odds ratios (SEs) and 
P-values are reported for T2D. 
S7 Table. Results of Mendelian Randomisation analyses performed in the UK Biobank 
dataset. External betas (log-ORs) were used as weights to generate the genetic risk scores 
used in IVreg2. SNP-phenotype associations were generated in STATA using 120,286 
unrelated white British individuals. 
S8 Table. Assocations statistics of the 16 Chronotype variants with BMI and type 2 
diabetes in the UK Biobank. Type 2 diabetes ORs and SEs were generated in a smaller 
subset of unrelated individuals as compared to the P-values, owing to limitations of Linear 
Mixed Models method. 
S9 Table. Output from the Broad Institute's HaploReg tool 
(http://www.broadinstitute.org/mammals/haploreg/haploreg.php) identifying missense 
coding variants within LD r2 ≥ 0.8 of four of the 22 lead chronotype variants. Only 
missense, nonsense, non-frameshift and frameshift variants are given in this table. No 
coding variants were found for sleep duration. 
S1 Fig. U-shaped association between sleep duration and both self-report BMI and 
type 2 diabetes prevalence. Average self-report BMI (left) and type 2 diabetes prevalence 
(right) over each of the sleep duration categories, calculated using the full UK Biobank 
cohort of 502,665 individuals. Error bars indicate standard error. Average BMI or type 2 
diabetes prevalence values with standard errors exceeding the plot limits were omitted. 
 
